- Home
- KYMR vs CWEN Comparison
KYMR vs CWEN Comparison
Compare KYMR & CWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- CWEN
- Stock Information
- Founded
- KYMR 2015
- CWEN 2012
- Country
- KYMR United States
- CWEN United States
- Employees
- KYMR N/A
- CWEN N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- CWEN Electric Utilities: Central
- Sector
- KYMR Health Care
- CWEN Utilities
- Exchange
- KYMR Nasdaq
- CWEN Nasdaq
- Market Cap
- KYMR 3.1B
- CWEN 3.7B
- IPO Year
- KYMR 2020
- CWEN 2013
- Fundamental
- Price
- KYMR $44.91
- CWEN $32.22
- Analyst Decision
- KYMR Strong Buy
- CWEN Strong Buy
- Analyst Count
- KYMR 16
- CWEN 4
- Target Price
- KYMR $58.94
- CWEN $35.75
- AVG Volume (30 Days)
- KYMR 875.7K
- CWEN 933.0K
- Earning Date
- KYMR 08-06-2025
- CWEN 08-05-2025
- Dividend Yield
- KYMR N/A
- CWEN 5.31%
- EPS Growth
- KYMR N/A
- CWEN 20.79
- EPS
- KYMR N/A
- CWEN 0.79
- Revenue
- KYMR $58,885,000.00
- CWEN $1,406,000,000.00
- Revenue This Year
- KYMR $58.26
- CWEN $8.32
- Revenue Next Year
- KYMR N/A
- CWEN $10.84
- P/E Ratio
- KYMR N/A
- CWEN $40.54
- Revenue Growth
- KYMR N/A
- CWEN 9.08
- 52 Week Low
- KYMR $19.45
- CWEN $24.40
- 52 Week High
- KYMR $53.27
- CWEN $32.76
- Technical
- Relative Strength Index (RSI)
- KYMR 56.82
- CWEN 55.61
- Support Level
- KYMR $43.56
- CWEN $31.73
- Resistance Level
- KYMR $45.83
- CWEN $32.48
- Average True Range (ATR)
- KYMR 1.77
- CWEN 0.66
- MACD
- KYMR -0.49
- CWEN -0.07
- Stochastic Oscillator
- KYMR 51.65
- CWEN 67.27
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About CWEN Clearway Energy Inc. Class C
Clearway Energy Inc is a publicly-traded energy infrastructure investor with a focus on investments in clean energy and owner of modern, sustainable and long-term contracted assets across North America. The company segments its operations into Flexible Generation, renewables and Corporate divisions.